| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | L-lactate dehydrogenase A chain|LDH-A|Cell proliferation-inducing gene 19 protein|LDH muscle subunit|LDH-M|Renal carcinoma antigen NY-REN-59|LDHA |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
rat Ldha (L-lactate dehydrogenase A chain) (LDH) is a molecular target commonly studied in cardiovascular and metabolism research. Enzymes contribute to cellular physiology through catalytic activity that supports metabolism, nucleic-acid processing, or signaling.
Biological role and mechanism
The biological role of Ldha is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Ldha can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Ldha (L-lactate dehydrogenase A chain) (LDH) may also be referenced as L-lactate dehydrogenase A chain, LDH-A, and Cell proliferation-inducing gene 19 protein in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Ldha relates to vascular biology and endothelial function, cardiac remodeling and injury responses, thrombosis and hemostasis, and blood pressure regulation in cardiovascular and metabolism research.
- Interpreting shifts in Ldha levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Ldha has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with cardiovascular and metabolism studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Mitochondrial modulation of amplified preconditioning influences of remote ischemia plus erythropoietin against skeletal muscle ischemia/reperfusion injury in rats
IF: 6.1 Journal: Life Sciences Author: Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Pharos University in Alexandria, Alexandria, Egypt Cited Date: 2023-08-04
Olmesartan attenuates doxorubicin-elicited testicular toxicity: The interaction between sirtuin-1, HMGB1/NLRP3 inflammasome/gasdermin D signaling, and AMPK/mTOR-driven autophagy
IF: 5.2 Journal: Life Sciences Author: Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia. Cited Date: 2025-03-14
Astaxanthin mitigates diabetic cardiomyopathy and nephropathyin HF/HFr/STZ diabetic rats via modulating NOX4, fractalkine, Nrf2, and AP-1 pathways
IF: 3.8 Journal: Scientific Reports Author: Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Bohouth St., Dokki, P.O. 12622, Cairo, Egypt. Cited Date: 2025-06-27
Ambrisentan ameliorates methotrexate-induced pulmonary injury in rats: involvement of ET-1/ETA, NF-κB, and MMP-9/TIMP-1 pathways
IF: 3.4 Journal: Toxicology and Applied Pharmacology Author: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. Cited Date: 2025-11-21
Protective effect of ginsenoside Rb1 against aconitine cardiotoxicity studied by myocardial injury, action potential, and calcium signaling
IF: 2.8 Journal: Toxicon Author: State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China. Cited Date: 2024-03-29
Platelet-rich plasma enhances remodeling of combined gastrocnemius muscle and achilles tendon injuries in rat model: Reducing fibrosis, modulating gene (MMP9, Bax, HMGB1, and IGF) expression, and restoring histopathological and ultrastructural changes
IF: 2.7 Journal: Tissue and Cell Author: Human Anatomy and embryology department, Faculty of Medicine, Zagazig University,Egypt. Cited Date: 2025-01-03
Influence of Ginsenoside Rh2 on Cardiomyocyte Pyroptosis in Rats with Acute Myocardial Infarction
IF: 2.65 Journal: Evidence-Based Complementary and Alternative Medicine Cited Date: 2022-10-20